Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

Most cancer deaths among white Americans could be prevented through four healthy lifestyle changes

Lifestyle Factors Can Significantly Affect Cancer Mortality

Four key lifestyle factors include weight, exercise, no smoking, and limiting alcohol
Precision cancer treatment that's guided by genetic clues from the patient's own tumor appears to improve outcomes

ASCO: Phase I Cancer Drug Trials Benefit From Precision Medicine

Better outcomes for patients whose treatment is selected based on molecular characteristics of tumor
Palliative care that's offered soon after a terminal cancer diagnosis can also help caregivers

ASCO: Early Palliative Care Beneficial for Caregivers

Such programs improve quality of life for people caring for terminal cancer patients
While powerful HIV medications are allowing patients to live longer

Cancer Treatment Lacking for HIV-Infected Patients

But it's not clear what's driving the difference in care, researcher says
Exercise may significantly reduce risk for many types of cancer

Physical Activity Associated With Lower Risk of Many Cancers

Findings for self-reported leisure-time physical activity of moderate to vigorous intensity
For cancer screening in Medicare beneficiaries

Agreement High for Prognostic Cancer Screening Tools

High rates of screening for individuals with limited long-term life expectancy for all tools
Regular aspirin use may lower the risk of bile duct cancer

Regular Aspirin Use May Protect Against Bile Duct Cancer

People who took it regularly were three times less likely to develop the disease
All-cause and certain cause-specific mortality rates have decreased recently among those with type 1 and 2 diabetes

All-Cause, CVD, DM Mortality Down From 2000 to 2011

Decreases seen in type 1 and 2 diabetes; no change in age-standardized cancer-specific mortality
The addition of antiviral therapy to sorafenib is a cost-effective option compared with sorafenib monotherapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma in China

Adding Antiviral to Sorafenib Is Cost-Effective in HCC

More cost-effective than sorafenib monotherapy for HBV-related cancer

April 2016 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for April 2016. This roundup includes...